Researchers in Nikolaus Rajewsky's lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to map a tumor's cellular neighborhoods in 3D and identify potential targets ...

The following is a summary of "ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is ...

A study shows that lymphovascular invasion is a significant predictor of metastasis and disease-specific death in patients ...

In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

The FDA has granted clearance to an investigational new drug application for CLD-201 for solid tumor treatment, based on ...

The following is a summary of "Novel devices and biomarkers in screening for esophageal squamous cell cancer," published in ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...

A phase 1b trial is evaluating PH-762 for the treatment of cutaneous squamous cell carcinoma, melanoma and Merkel cell carcinoma.

1University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.